TXG

10 X Genomics Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↑ 8/10
  • Value↓ 1/10
10 X Genomics sales and earnings growth
TXG Growth
Good
  • Revenue Y/Y↓ 2.26%
  • EPS Y/Y↑ 87.02%
  • FCF Y/Y↑ 169.33%
10 X Genomics gross and profit margin trends
TXG Profitability
Fair
  • Gross margin ↑ 69.60%
  • EPS margin↓ -3.50%
  • ROIC 5Y↓ -27.36%
10 X Genomics net debt vs free cash flow
TXG Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

10 X Genomics stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Health Information Services stocks